- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
BREAKING in Cancer Research- Orphan Drug Designation for BP2202
"BREAKING in Cancer Research!"
🧬 BrightPath’s BP2202 has just received FDA Orphan Drug Designation for Multiple Myeloma!
💉 This cutting-edge CAR-NKT cell therapy is designed to fight one of the most stubborn blood cancers — even for patients who've run out of options.
🚀 With a U.S. clinical trial on the way, BP2202 brings new hope to thousands battling multiple myeloma.
✅ Follow ClinOrbit for more reliable cancer breakthroughs!
⚠️ This video contains AI-generated voiceover for informational purposes. No real individuals are speaking.
Видео BREAKING in Cancer Research- Orphan Drug Designation for BP2202 канала ClinOrbit
🧬 BrightPath’s BP2202 has just received FDA Orphan Drug Designation for Multiple Myeloma!
💉 This cutting-edge CAR-NKT cell therapy is designed to fight one of the most stubborn blood cancers — even for patients who've run out of options.
🚀 With a U.S. clinical trial on the way, BP2202 brings new hope to thousands battling multiple myeloma.
✅ Follow ClinOrbit for more reliable cancer breakthroughs!
⚠️ This video contains AI-generated voiceover for informational purposes. No real individuals are speaking.
Видео BREAKING in Cancer Research- Orphan Drug Designation for BP2202 канала ClinOrbit
Комментарии отсутствуют
Информация о видео
6 июля 2025 г. 22:21:40
00:00:59
Другие видео канала
FDA Clears IND for New Bispecific Antibody AXN 2510 for Solid Tumors!
FDA approved ANZUPGO® delgocitinib cream 20 mgg for moderate to severe chronic hand eczema CHE
FDA has accepted and granted Priority Review for tabelecleucel
FDA Approves EKTERLY® (sebetralstat)-First Oral On-Demand Treatment for Hereditary Angioedema!
New Hope for Lung Cancer: China Approves ORPATHYS & TAGRISSO Combo
Deramiocel BLA Update: Capricor & FDA
FDA Approves SIR-Spheres® Y-90 for Liver Cancer!
sNDA for toripalimab + disitamab vedotin as 1L HER2 expressing urothelial carcinoma
Corcept Files NDA for Ovarian Cancer Drug Relacorilant!
PAH Breakthrough: Winrevair Gets FDA Priority Review
Orphan Drug Status to a potential breakthrough treatment — SPG601 from Spinogenix!
sNDA submitted to U S FDA for CAPLYTA® lumateperone
Big leap in kidney disease treatment!IND for PS-002 approved by FDA for IgAN
FDA granted Orphan Drug Designation to Mustang Bio’s MB-101 to Treat Astrocytomas and Glioblastoma
ENHERTU plus pertuzumab: Granted Breakthrough Therapy Designation by the U.S. FDA!
U S FDA approved an expanded indication for AJOVY® fremanezumab vfrm for episodic migraine
Swissmedic has approved IFINWIL® for paediatric patients with high-risk neuroblastoma
IXCHIQ® Cleared for Elderly Use in EU!
U S FDA granted accelerated approval to Boehringer Ingelheim’s HERNEXEOS® zongertinib
European Commission Approved TEVIMBRA tislelizumab for Nasopharyngeal Carcinoma
